TXA reduces rebleed rate: RR 0.33 (95% CI 0.21 to 0.53)
ACA reduces rebleed rate: RR 0.28 (95% CI 0.13 to 0.60)
TXA generally preferred due to fewer GI adverse effects
Neither agent alters final visual acuity in meta-analysis
Role of topical corticosteroids
Reduce traumatic uveitis and anterior synechiae formation
Prednisolone acetate 1% QID is standard
Systemic corticosteroids not routinely used
IOP management principles
Trabecular meshwork obstruction is primary mechanism
Aqueous production suppression is first-line approach
Beta-blockers and alpha-2 agonists most commonly used topically
Surgical decompression when medical therapy fails
Clot washout most effective for corneal staining prevention
Timing at day 4 to allow clot liquefaction improves success
Prevention of long-term sequelae
Annual IOP check indefinitely after traumatic hyphema
Angle recession glaucoma risk persists for decades
Gonioscopy after resolution to assess angle recession extent
Protective eyewear counseling to prevent recurrence
Limitations of evidence
Most RCTs for antifibrinolytics are underpowered
Optimal management varies by institution and resource availability
Sickle cell subgroup data largely from observational case series
Patient Discharge Instructions
copy discharge instructions
Home care instructions for hyphema
Eye shield: wear rigid Fox eye shield at all times including during sleep
Head position: sleep and rest with head elevated >= 30 degrees
Activity: no sports, exercise, heavy lifting, bending, or straining for 5 to 7 days
Reading: avoid near work and reading (iris movement increases rebleed risk)
Medications to take at home
Atropine eye drops: 1 drop every 8 hours as prescribed
Prednisolone acetate eye drops: 1 drop four times daily as prescribed
Antifibrinolytic tablets if prescribed: take with food, complete full 5-day course
Acetaminophen for pain: 500 to 1000 mg as needed, do not exceed 4000 mg per day
Medications to avoid
No ibuprofen, aspirin, naproxen, or any anti-inflammatory pain reliever
No blood thinners unless directed by your doctor
Avoid alcohol during recovery (affects platelet function)
Return to emergency department immediately if
Sudden worsening or new loss of vision
Severe eye pain or pressure building
New or increasing headache with nausea or vomiting
Blood level in the eye appears to be rising or worsening
Increasing sensitivity to light
Seeing flashes of light or new floaters
Nausea or vomiting that does not settle
Follow-up instructions
Ophthalmology appointment: within 24 to 48 hours — this is essential
Peak risk of re-bleeding is days 3 to 5 after injury
Most small hyphemas resolve within 5 to 7 days
Long-term: annual eye pressure checks even after full recovery to monitor for glaucoma
References
Guidelines and key sources
Primary evidence sources
Woreta FA, Lindsley KB, Gharaibeh A, et al. Medical Interventions for Traumatic Hyphema. Cochrane Database of Systematic Reviews. 2023
Antifibrinolytic meta-analysis supporting TXA and ACA use
TXA: RR 0.33; ACA: RR 0.28 for rebleed prevention
Paterson R, Drake B, Tabin G, Cushing T. Wilderness Medical Society Clinical Practice Guidelines for Eye Injuries. Wilderness and Environmental Medicine. 2024
Shingleton BJ. Eye Injuries. New England Journal of Medicine. 1991
Walton W, Von Hagen S, Grigorian R, Zarbin M. Management of Traumatic Hyphema. Survey of Ophthalmology. 2002
Epidemiology and outcomes references
Iftikhar M, Mir T, Seidel N, et al. Epidemiology and Outcomes of Hyphema. Acta Ophthalmologica. 2021
Papaconstantinou D, et al. Contemporary Aspects in the Prognosis of Traumatic Hyphemas. Clinical Ophthalmology. 2009
Miller SC, Meeralakshmi P, Fliotsos MJ, et al. Global Current Practice Patterns for Management of Hyphema. Clinical Ophthalmology. 2022
Sickle cell and special population references
Mir T, Iftikhar M, Seidel N, et al. Hyphema in Patients With Sickle Cell Trait: 10-Year Experience at Wilmer Eye Institute. Clinical Ophthalmology. 2020
Wax MB, Ridley ME, Magargal LE. Reversal of Retinal and Optic Disc Ischemia in Sickle Cell Trait and Glaucoma Secondary to Traumatic Hyphema. Ophthalmology. 1982
Surgical references
Graul TA, Ruttum MS, Lloyd MA, et al. Trabeculectomy for Traumatic Hyphema With Increased Intraocular Pressure. American Journal of Ophthalmology. 1994
Rahmani B, Jahadi HR. Comparison of Tranexamic Acid and Prednisolone in Treatment of Traumatic Hyphema. Ophthalmology. 1999
Coding standards
ICD-10 H21.0 Hyphema
ICD-10 S05.10 Contusion of eyeball and orbital tissues
SNOMED CT 75249002 Hyphema
SymptomDx is an educational tool for medical professionals. It does not replace clinical judgment. Verify all clinical data and drug dosages with authoritative sources.